{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:35:35Z","timestamp":1790339735651,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T00:00:00Z","timestamp":1284681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00259-010-1604-0","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T14:57:14Z","timestamp":1284649034000},"page":"55-63","source":"Crossref","is-referenced-by-count":146,"title":["Is there a role for 11C-choline PET\/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase &lt;1.5\u00a0ng\/ml?"],"prefix":"10.1007","volume":"38","author":[{"given":"Paolo","family":"Castellucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,17]]},"reference":[{"issue":"Suppl 1","key":"1604_CR1","doi-asserted-by":"crossref","first-page":"i34","DOI":"10.1093\/annonc\/mdi826","volume":"16","author":"VV Kataja","year":"2005","unstructured":"Kataja VV, Bergh J. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer. Ann Oncol 2005;16 Suppl 1:i34\u20136.","journal-title":"Ann Oncol"},{"key":"1604_CR2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(02)02526-8","volume":"61","author":"SJ Freedland","year":"2003","unstructured":"Freedland SJ, Presti JC Jr, Amling CL, Kane CJ, Aronson WJ, Dorey F, et al. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 2003;61:736\u201341.","journal-title":"Urology"},{"key":"1604_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","volume":"169","author":"M Han","year":"2003","unstructured":"Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517\u201323.","journal-title":"J Urol"},{"issue":"20","key":"1604_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijrobp.2003.10.059","volume":"59","author":"DB Chism","year":"2004","unstructured":"Chism DB, Hanlon AL, Horwitz EM, Feigenberg SJ, Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 2004;59(20):380\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1604_CR5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0025-6196(11)62406-3","volume":"76","author":"SG Roberts","year":"2001","unstructured":"Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 2001;76:576\u201381.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1604_CR6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.juro.2007.10.059","volume":"179","author":"TK Choueiri","year":"2008","unstructured":"Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol 2008;179(3):906\u201310.","journal-title":"J Urol"},{"key":"1604_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clon.2009.10.015","volume":"22","author":"MJ Beresford","year":"2010","unstructured":"Beresford MJ, Gillatt D, Benson RI, Ajithkumar T. A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clin Oncol (R Coll Radiol) 2010;22:46\u201355.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"1604_CR8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1368-5031.2004.00184.x","volume":"58","author":"L Boccon-Gibod","year":"2004","unstructured":"Boccon-Gibod L, Djavan WB, Hammerer P, Hoeltl W, Kattan MW, Prayer-Galetti T, et al. Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract 2004;58(4):382\u201390.","journal-title":"Int J Clin Pract"},{"key":"1604_CR9","first-page":"990","volume":"39","author":"T Hara","year":"1998","unstructured":"Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990\u20135.","journal-title":"J Nucl Med"},{"key":"1604_CR10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","volume":"33","author":"M Cimitan","year":"2006","unstructured":"Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET\/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387\u201398.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1604_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","volume":"35","author":"BJ Krause","year":"2008","unstructured":"Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C, et al. The detection rate of [11C]choline-PET\/TC depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:18\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1604_CR12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/01.ju.0000056901.95996.43","volume":"169","author":"M Picchio","year":"2003","unstructured":"Picchio M, Messa C, Landoni C, Gianolli L, Sironi S, Brioschi M, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337\u201340.","journal-title":"J Urol"},{"key":"1604_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1099-1344(200002)43:2<195::AID-JLCR316>3.0.CO;2-P","volume":"49","author":"C Pascali","year":"2000","unstructured":"Pascali C, Bogni A, Itawa R, Cambi\u00e8 M, Bombardieri E. [11C]Methylation on a C18 Sep-Pak cartridge: a convenient way to produce [N-methyl-11C]choline. J Labelled Comp Radiopharm 2000;49:195\u2013203.","journal-title":"J Labelled Comp Radiopharm"},{"key":"1604_CR14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1097\/01.ju.0000097124.21878.6b","volume":"170","author":"MA Khan","year":"2003","unstructured":"Khan MA, Carter HB, Epstein JI, Miller MC, Landis P, Walsh PW, et al. Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J Urol 2003;170:2274\u20138.","journal-title":"J Urol"},{"key":"1604_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cncr.21696","volume":"106","author":"RS Svatek","year":"2006","unstructured":"Svatek RS, Shulman M, Choudhary PK, Benaim E. Critical analysis of prostate-specific antigen doubling time calculation methodology. Cancer 2006;106:1047\u201353.","journal-title":"Cancer"},{"key":"1604_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.nu.01.070181.000523","volume":"1","author":"SH Zeisel","year":"1981","unstructured":"Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1981;1:95\u2013121.","journal-title":"Annu Rev Nutr"},{"key":"1604_CR17","first-page":"3599","volume":"61","author":"E Ackerstaff","year":"2001","unstructured":"Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 2001;61:3599\u2013603.","journal-title":"Cancer Res"},{"key":"1604_CR18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","volume":"31","author":"E Sutinen","year":"2003","unstructured":"Sutinen E, Nurmi M, Roivainen A, Varpula M, Tolvanen T, Lehikoinen P, et al. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 2003;31:317\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1604_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1158\/0008-5472.CAN-07-2678","volume":"68","author":"K Glunde","year":"2008","unstructured":"Glunde K, Shah T, Winnard PT, Raman V, Takagi T, Vesuna F, et al. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Res 2008;68:172\u201380.","journal-title":"Cancer Res"},{"key":"1604_CR20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0022-5347(01)62545-X","volume":"160","author":"ML Cher","year":"1998","unstructured":"Cher ML, Bianco FJ, Lam JS, Davis LP, Grignon DJ, Sakr WA, et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 1998;160:1387\u201391.","journal-title":"J Urol"},{"key":"1604_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1464-410X.2004.04927.x","volume":"94","author":"P Gomez","year":"2004","unstructured":"Gomez P, Manoharan M, Kim SS, Soloway MS. Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int 2004;94:299\u2013302.","journal-title":"BJU Int"},{"key":"1604_CR22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiology.219.2.r01ma20432","volume":"219","author":"AK Leventis","year":"2001","unstructured":"Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001;219:432\u20139.","journal-title":"Radiology"},{"key":"1604_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0302-2838(03)00320-8","volume":"44","author":"V Scattoni","year":"2003","unstructured":"Scattoni V, Roscigno M, Raber M, Montorsi F, Da Pozzo L, Guazzoni G, et al. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 2003;44:407\u201314.","journal-title":"Eur Urol"},{"key":"1604_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","volume":"37","author":"G Giovacchini","year":"2010","unstructured":"Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, et al. Predictive factors of [(11)C]choline PET\/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 2010;37:301\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1604_CR25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","volume":"35","author":"DB Husarik","year":"2008","unstructured":"Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, et al. Evaluation of [(18)F]-choline PET\/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:253\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1604_CR26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2967\/jnumed.108.061507","volume":"50","author":"P Castellucci","year":"2009","unstructured":"Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, et al. Influence of trigger PSA and PSA kinetics on 11C-choline PET\/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 2009;50:1394\u2013400.","journal-title":"J Nucl Med"},{"key":"1604_CR27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00259-010-1403-7","volume":"37","author":"G Giovacchini","year":"2010","unstructured":"Giovacchini G, Picchio M, Scattoni V, Garcia Parra R, Briganti A, Gianolli L, et al. PSA doubling time for prediction of [(11)C]choline PET\/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 2010;37:1106\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1604-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1604-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1604-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:05:08Z","timestamp":1558713908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1604-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,17]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1604-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,17]]}}}